Gene · 54210
Papers3,294
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,294
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gingival crevicular fluid levels of soluble triggering receptor expressed on myeloid cells 1 in chronic periodontitis: A systematic review and meta-analysis. | Arch Oral Biol | 2026 | 41161062 | PubTator, text mining | PubMed |
| Targeting mesenchymal monocyte-derived macrophages to enhance the sensitivity of glioblastoma to temozolomide by inhibiting TNF/CELSR2/p65/Kla-HDAC1/EPAS1 axis. | J Adv Res | 2026 | 40373963 | PubTator, text mining | PubMed |
| Integrative Analysis Reveals Genes Causal Relation with Ovarian Cancer and aging. | Curr Top Med Chem | 2026 | 40353459 | PubTator, text mining | PubMed |
| Crucial role of microglia-mediated myelin sheath damage in vascular dementia: Antecedents and consequences. | Neural Regen Res | 2026 | 40145953 | PubTator, text mining | PubMed |
| Observations on the effect of enteral nutrition support on serum nutritional proteins, proinflammatory cytokines and immunoglobulins in patients with cerebral hemorrhage. | J Med Biochem | 2025 | 41799182 | PubTator, text mining | PubMed |
| Human molecular mechanisms of lumbar disc degeneration: A scoping review. | Spine Open | 2025 | 41585630 | PubTator, text mining | PubMed |
Evaluation of the Diagnostic Performance of Interleukin-6, C-reactive Protein, and Soluble Triggering Receptor Expressed on Myeloid Cells-1, Individually and Combined, in Differentiating Candidemia from Bacteremia in Intensive Care Unit Patients. | J Glob Infect Dis | 2025 | 41583950 | PubTator, text mining | PubMed |
| [Construction and Clinical Validation of a Risk Early Warning Model for Mechanical Ventilation-Associated Pneumonia in Older Patients With Lung Cancer]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2025 | 41536672 | PubTator, text mining | PubMed |
| Development of a novel diagnostic model for Alzheimer's disease based on glymphatic system and metabolism-related genes. | Front Mol Biosci | 2025 | 41427016 | PubTator, text mining | PubMed |
| Immunophenotyping of septic shock patients with endotheliopathy: focus on monocyte subtypes and Immune regulatory molecules. | Front Immunol | 2025 | 41425588 | PubTator, text mining | PubMed |
| Exploring the interaction mechanisms of CD46/TREM1 and LC3B/ATG5 in the inflammation-cancer transformation of oral squamous cell carcinoma based on bioinformatics. | Front Mol Biosci | 2025 | 41415031 | PubTator, text mining | PubMed |
| Pan-cancer analysis reveals TREM1+ PMN-MDSCs as critical regulators of immune suppression and tumor microenvironment remodeling. | Commun Biol | 2025 | 41413734 | PubTator, text mining | PubMed |
| Role of TREM1 in the sevoflurane-induced inflammatory activation of microglia in vitro. | Ibrain | 2025 | 41395449 | PubTator, text mining | PubMed |
| Unveiling the novel value of TREM1 in the proneural-mesenchymal transition of glioma via tumor-associated macrophages. | Front Immunol | 2025 | 41394801 | PubTator, text mining | PubMed |
| TREM1 in sepsis-associated acute kidney injury: translational and mechanistic considerations. | Int J Surg | 2025 | 41376577 | PubTator, text mining | PubMed |
| High-Throughput Fragment Screening Identifies a New Small Molecule Scaffold that Modulates TREM2 Signaling. | bioRxiv | 2025 | 41357984 | PubTator, text mining | PubMed |
| As48, a first-in-class dual-function TREM2 modulator: Receptor activation and shedding inhibition. | Biomed Pharmacother | 2025 | 41337883 | PubTator, text mining | PubMed |
| Comprehensive Plasma Oxylipin Profiling Reveals a Pro-Inflammatory Eicosanoid Signature and Diagnostic Biomarker Panel in Dilated Cardiomyopathy. | Med Sci Monit | 2025 | 41327761 | PubTator, text mining | PubMed |
| Epithelial pyroptosis-induced TREM1+ macrophages activate Th17 cells to accelerate oral mucosal inflammation. | Cell Death Discov | 2025 | 41318555 | PubTator, text mining | PubMed |
| Engineered Fenretinide- and Tocilizumab-Releasing Janus Nanoparticles for Site-Directed Immunochemoprevention of Squamous Cell Carcinoma of the Lung. | Pharmaceutics | 2025 | 41304808 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54210/papers?page=7